Endothelium-Derived Relaxing Factor: Are There Alternatives to the Role of Nitric Oxide?
- 1 December 1989
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 7 (4), 326-327
- https://doi.org/10.1111/j.1527-3466.1989.tb00535.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- An Improved Chemiluminescence Assay Suggests NGN Nitric Oxide-Mediated Action of Lysophosphatidylcholine and AcetylcholineExperimental Biology and Medicine, 1989
- Lysolecithins as endothelium-dependent vascular smooth muscle relaxants that differ from endothelium-derived relaxing factor (nitric oxide)Proceedings of the National Academy of Sciences, 1988
- Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agentsChemical Research in Toxicology, 1988
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Crucial role of endothelium in the vasodilator response to increased flow in vivo.Hypertension, 1986
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980